Point-of-care testing for infectious diseases: Opportunities, barriers, and considerations in community pharmacy

被引:74
|
作者
Gubbins, Paul O. [1 ]
Klepser, Michael E. [2 ]
Dering-Anderson, Allison M. [3 ]
Bauer, Karri A. [4 ]
Darin, Kristin M. [5 ]
Klepser, Stephanie [6 ]
Matthias, Kathryn R. [7 ]
Scarsi, Kimberly [8 ]
机构
[1] Missouri State Univ, Sch Pharm, Univ Missouri Kansas City, Springfield, MO 65806 USA
[2] Ferris State Univ, Coll Pharm, Dept Pharm Practice, Kalamazoo, MI USA
[3] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE USA
[4] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
[5] Northwestern Univ, Ctr Global Hlth, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Kalamazoo Ctr Med Studies Pharm, Kalamazoo, MI USA
[7] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[8] Univ Nebraska Med Ctr, Coll Pharm, Omaha, NE USA
关键词
Rapid diagnostic tests; Clinical Laboratory Improvement Amendments; collaborative practice; pharmacy services; laws and legislation; SERVICES; VACCINATION;
D O I
10.1331/JAPhA.2014.13167
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To identify opportunities to perform point-of-care (POC) testing and/or screening for infectious diseases in community pharmacies, provide an overview of such tests and how they are used in current practice, discuss how the Clinical Laboratory Improvement Amendments of 1988 (CLIA) affect pharmacists performing POC testing, and identify and discuss barriers and provide recommendations for those wanting to establish POC testing for infectious diseases services in community pharmacies. Data sources: PubMed and Google Scholar were searched from November 2012 through May 2013 and encompassed the years 2000 and beyond for the narrative review section of this article using the search terms rapid diagnostic tests, POC testing and infectious diseases, pharmacy services, CLIA waiver, and collaborative drug therapy management. All state boards of pharmacy in the United States were contacted and their regulatory and legislative websites accessed in 2012 and January 2013 to review relevant pharmacy practice laws. Data synthesis: POC testing for infectious diseases represents a significant opportunity to expand services in community pharmacies. Pharmacist education and training are addressing knowledge deficits in good laboratory practices and test performance and interpretation. Federal regulations do not define the qualifications for those who perform CLIA-waived tests, yet few pharmacists perform such services. Fewer than 20% of states address POC testing in their statutes and regulations governing pharmacy. Conclusion: POC testing for infectious diseases could benefit patients and society and represents an opportunity to expand pharmacy services in community pharmacies. Existing barriers to the implementation of such services in community pharmacies, including deficits in pharmacist training and education along with state regulatory and legislative variance and vagueness in statutes governing pharmacy, are not insurmountable.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 50 条
  • [1] Pharmacy-based point-of-care testing for infectious diseases: Considerations for the pharmacy curriculum
    Akinwale, Tolu P.
    Adams, Alex J.
    Dering-Anderson, Allison M.
    Klepser, Michael E.
    [J]. CURRENTS IN PHARMACY TEACHING AND LEARNING, 2015, 7 (01) : 131 - 136
  • [2] Point-of-care testing and the control of infectious diseases
    Hanafiah, Khayriyyah Mohd
    Garcia, Mary
    Anderson, David
    [J]. BIOMARKERS IN MEDICINE, 2013, 7 (03) : 333 - 347
  • [3] Point-of-care Testing in Pediatric Infectious Diseases
    Keitel, Kristina
    Lacroix, Laurence
    Gervaix, Alain
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (01) : 108 - 110
  • [4] Implications of and legal barriers to community pharmacy-based point-of-care testing services
    Klepser, Donald
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2015, 55 (06) : 573 - 574
  • [5] Point-of-care testing of infectious diseases: recent advances
    Shang, Meiyun
    Guo, Jiuchuan
    Guo, Jinhong
    [J]. SENSORS & DIAGNOSTICS, 2023, 2 (05): : 1123 - 1144
  • [6] Point-of-care nucleic acid testing for infectious diseases
    Niemz, Angelika
    Ferguson, Tanya M.
    Boyle, David S.
    [J]. TRENDS IN BIOTECHNOLOGY, 2011, 29 (05) : 240 - 250
  • [7] Supplementary pharmacist prescribing and point-of-care testing in community pharmacy
    Micallef, T.
    Azzopardi, L. M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 240 - 240
  • [8] Point-of-Care Testing for Infectious Diseases: Past, Present, and Future
    Kozel, Thomas R.
    Burnham-Marusich, Amanda R.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (08) : 2313 - 2320
  • [9] Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases
    Gubbins, Paul O.
    Klepser, Michael E.
    Adams, Alex J.
    Jacobs, David M.
    Percival, Kelly M.
    Tallman, Gregory B.
    [J]. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2017, 23 (06): : 593 - 600
  • [10] Point-of-Care Testing for Pharyngitis in the Pharmacy
    Essack, Sabiha
    Bell, John
    Burgoyne, Douglas
    Tongrod, Wirat
    Duerden, Martin
    Sessa, Aurelio
    Altiner, Attila
    Shephard, Adrian
    [J]. ANTIBIOTICS-BASEL, 2020, 9 (11): : 1 - 16